SEC
TECH icon

Seven Eight Capital’s Bio-Techne TECH Stock Holding History

Seven Eight Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,080
Closed -$569K – 894
2024
Q1 		$569K Buy
+8,080
New +$578K 0.06% 431
2023
Q4 		– Sell
-6,094
Closed -$415K – 828
2023
Q3 		$415K Buy
+6,094
New +$481K 0.05% 431
2020
Q2 		– Sell
-4,800
Closed -$228K – 546
2020
Q1 		$228K Buy
+4,800
New +$240K 0.06% 375
2019
Q4 		– Sell
-5,636
Closed -$276K – 767
2019
Q3 		$276K Buy
+5,636
New +$283K 0.01% 555

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Seven Eight Capital's TECH Position: Q2 2024 in Review

Seven Eight Capital sold out of Bio-Techne (TECH) in Q2 2024, closing a stake of 8,080 shares — an estimated $569K sold.

Seven Eight Capital first reported a position in TECH in Q3 2019 and held it in 4 quarters. The position peaked at $569K in Q1 2024. 572 funds tracked by Wall St. Rank hold TECH as of Q2 2024.

  • Seven Eight Capital reported no remaining Bio-Techne position as of Q2 2024 after selling out during the quarter.
  • Seven Eight Capital sold 8,080 Bio-Techne shares in Q2 2024, an estimated $569K.
  • Seven Eight Capital first reported a position in Bio-Techne in Q3 2019 and held it in 4 quarters.
  • Seven Eight Capital's Bio-Techne position peaked at $569K in Q1 2024.
  • 572 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2024.

Based on Seven Eight Capital's 13F filing for Q2 2024, filed 12 Aug 2024.